drugset / Trial / NCT02327013

Investigating the Effect of Vortioxetine in Adult ADHD Patients

NCT02327013

Phase 2 Completed 227 enrolled H. Lundbeck A/S
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose is to determine the effect of vortioxetine treatment on ADHD symptoms in adult patients with ADHD in a 12 weeks study.

Timeline

Start
2014-12
Primary completion
2016-09
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 10 mg Oral
Subject Vortioxetine Unknown 20 mg Oral